| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Medicine (P.L.A., J.K., M.R., J.L.B., J.D.B., J.R.B.) and Surgery (N.W.T.), University of Michigan Medical School, Ann Arbor, Michigan 48109-0666
Address all correspondence and requests for reprints to: James R. Baker, Jr., University of Michigan Medical School, 1520 MSRB I, Ann Arbor, Michigan 48109-0666.
To determine whether thyroid cell apoptosis observed in autoimmune
thyroid disease could be related to activation of the Fas pathway, we
examined the expression and function of Fas on thyroid follicular cells
in vitro. Fas messenger RNA was found to be present
using two different techniques and was expressed at equal levels in
thyrocytes cultured either in the presence or absence of TSH. Fas
antigen protein expression was demonstrated by Western blot of thyroid
cell lysates and by immunohistochemical staining of thyrocytes, and the
amount of Fas protein present did not appear to vary regardless of
culture conditions. Despite expressing substantial amounts of Fas
protein, thyrocytes treated with anti-Fas monoclonal antibody failed to
undergo apoptosis. The addition of either interferon-
or
interleukin-1ß to the anti-Fas-treated cell cultures also did not
promote apoptotic signaling through this pathway. In contrast, the
concomitant administration of cycloheximide allowed the induction of
apoptosis through the activation of Fas in thyrocytes. These results
suggest that Fas is constitutively expressed in thyrocytes, but that
the induction of apoptosis through the Fas pathway is blocked by a
labile protein inhibitor.
This article has been cited by other articles:
![]() |
S. Fountoulakis, G. Vartholomatos, N. Kolaitis, S. Frillingos, G. Philippou, and A. Tsatsoulis Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur. J. Endocrinol., June 1, 2008; 158(6): 853 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Du, H.-Q. Wang, H.-Y. Zhang, and D.-X. Gao Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Death of Thyroid Cancer Cells Endocrinology, September 1, 2007; 148(9): 4352 - 4361. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Mitsiades, V. Poulaki, G. Fanourakis, E. Sozopoulos, D. McMillin, Z. Wen, G. Voutsinas, S. Tseleni-Balafouta, and N. Mitsiades Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin. Cancer Res., June 15, 2006; 12(12): 3705 - 3712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wang, Z. Cao, J. M. Wolf, M. Van Antwerp, and J. R. Baker Jr. Death Ligand Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis Endocrinology, November 1, 2005; 146(11): 4721 - 4726. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr. Induction and Regulation of Fas-Mediated Apoptosis in Human Thyroid Epithelial Cells Mol. Endocrinol., March 1, 2005; 19(3): 804 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mezosi, S. H. Wang, S. Utsugi, L. Bajnok, J. D. Bretz, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr. Interleukin-1{beta} and Tumor Necrosis Factor (TNF)-{alpha} Sensitize Human Thyroid Epithelial Cells to TNF-Related Apoptosis-Inducing Ligand-Induced Apoptosis through Increases in Procaspase-7 and Bid, and the Down-Regulation of p44/42 Mitogen-Activated Protein Kinase Activity J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 250 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mezosi, H. Yamazaki, J. D. Bretz, S. H. Wang, P. L. Arscott, S. Utsugi, P. G. Gauger, N. W. Thompson, and J. R. Baker Jr. Aberrant Apoptosis in Thyroid Epithelial Cells from Goiter Nodules J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4264 - 4272. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poulaki, C. S. Mitsiades, V. Kotoula, S. Tseleni-Balafouta, A. Ashkenazi, D. A. Koutras, and N. Mitsiades Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2002; 161(2): 643 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wang, J. D. Bretz, E. Phelps, E. Mezosi, P. L. Arscott, S. Utsugi, and J. R. Baker Jr. A Unique Combination of Inflammatory Cytokines Enhances Apoptosis of Thyroid Follicular Cells and Transforms Nondestructive to Destructive Thyroiditis in Experimental Autoimmune Thyroiditis J. Immunol., March 1, 2002; 168(5): 2470 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Feldkamp, E. Pascher, M. Schott, P. Goretzki, J. Seissler, and W. A. Scherbaum Soluble Fas Is Increased in Hyperthyroidism Independent of the Underlying Thyroid Disease J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4250 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tourneur, B. Malassagne, F. Batteux, M. Fabre, S. Mistou, E. Lallemand, P. Lores, and G. Chiocchia Transgenic Expression of CD95 Ligand on Thyroid Follicular Cells Confers Immune Privilege upon Thyroid Allografts J. Immunol., August 1, 2001; 167(3): 1338 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Nikiforova, J. R. Stringer, R. Blough, M. Medvedovic, J. A. Fagin, and Y. E. Nikiforov Proximity of Chromosomal Loci That Participate in Radiation-Induced Rearrangements in Human Cells Science, October 6, 2000; 290(5489): 138 - 141. [Abstract] [Full Text] |
||||
![]() |
S. Francavilla, P. DAbrizio, N. Rucci, G. Silvano, G. Properzi, E. Straface, G. Cordeschi, S. Necozione, L. Gnessi, M. Arizzi, et al. Fas and Fas Ligand Expression in Fetal and Adult Human Testis with Normal or Deranged Spermatogenesis J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2692 - 2700. [Abstract] [Full Text] |
||||
![]() |
N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, D. A. Koutras, and I. Stamenkovic Thyroid Carcinoma Cells Are Resistant to FAS-mediated Apoptosis But Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand Cancer Res., August 1, 2000; 60(15): 4122 - 4129. [Abstract] [Full Text] |
||||
![]() |
S. M. Quirk, R. M. Harman, S. C. Huber, and R. G. Cowan Responsiveness of Mouse Corpora Luteal Cells to Fas Antigen (CD95)-Mediated Apoptosis Biol Reprod, July 1, 2000; 63(1): 49 - 56. [Abstract] [Full Text] |
||||
![]() |
F. Batteux, P. Lores, D. Bucchini, and G. Chiocchia Transgenic Expression of Fas Ligand on Thyroid Follicular Cells Prevents Autoimmune Thyroiditis J. Immunol., February 15, 2000; 164(4): 1681 - 1688. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Vickers, R. G. Cowan, R. M. Harman, D. A. Porter, and S. M. Quirk Expression and Activity of the Fas Antigen in Bovine Ovarian Follicle Cells Biol Reprod, January 1, 2000; 62(1): 54 - 61. [Abstract] [Full Text] |
||||
![]() |
D. A. Porter, S. L. Vickers, R. G. Cowan, S. C. Huber, and S. M. Quirk Expression and Function of Fas Antigen Vary in Bovine Granulosa and Theca Cells During Ovarian Follicular Development and Atresia Biol Reprod, January 1, 2000; 62(1): 62 - 66. [Abstract] [Full Text] |
||||
![]() |
P. L. Arscott, T. Stokes, A. Myc, T. J. Giordano, N. W. Thompson, and J. R. Baker Jr. Fas (CD95) Expression is Up-Regulated on Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4246 - 4252. [Abstract] [Full Text] |
||||
![]() |
J. D. Bretz, P. L. Arscott, A. Myc, and J. R. Baker Jr. Inflammatory Cytokine Regulation of Fas-mediated Apoptosis in Thyroid Follicular Cells J. Biol. Chem., September 3, 1999; 274(36): 25433 - 25438. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Bretz, M. Rymaszewski, P. L. Arscott, A. Myc, K. B. Ain, N. W. Thompson, and J. R. Baker Jr. TRAIL Death Pathway Expression and Induction in Thyroid Follicular Cells J. Biol. Chem., August 13, 1999; 274(33): 23627 - 23632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiromatsu, T. Hoshino, H. Yagita, M. Koga, S. Sakisaka, J. Honda, D. Yang, N. Kayagaki, K. Okumura, and K. Nonaka Functional Fas Ligand Expression in Thyrocytes from Patients with Graves' Disease J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2896 - 2902. [Abstract] [Full Text] |
||||
![]() |
N. Mitsiades, V. Poulaki, G. Mastorakos, S. Tseleni-Balafouta, V. Kotoula, D. A. Koutras, and M. Tsokos Fas Ligand Expression in Thyroid Carcinomas: A Potential Mechanism of Immune Evasion J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2924 - 2932. [Abstract] [Full Text] |
||||
![]() |
N. Moulian, C. Renvoize, C. Desodt, A. Serraf, and S. Berrih-Aknin Functional Fas Expression in Human Thymic Epithelial Cells Blood, April 15, 1999; 93(8): 2660 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr. 1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death Endocrinology, April 1, 1999; 140(4): 1649 - 1656. [Abstract] [Full Text] |
||||
![]() |
F. Batteux, L. Tourneur, H. Trebeden, J. Charreire, and G. Chiocchia Gene Therapy of Experimental Autoimmune Thyroiditis by In Vivo Administration of Plasmid DNA Coding for Fas Ligand J. Immunol., January 1, 1999; 162(1): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Quirk, D. A. Porter, S. C. Huber, and R. G. Cowan Potentiation of Fas-Mediated Apoptosis of Murine Granulosa Cells by Interferon-{gamma}, Tumor Necrosis Factor-{alpha}, and Cycloheximide Endocrinology, December 1, 1998; 139(12): 4860 - 4869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamura, H. Kimura, T. Koji, T. Tominaga, K. Ashizawa, T. Kiriyama, N. Yokoyama, T. Yoshimura, K. Eguchi, P. K. Nakane, et al. Role of Apoptosis of Thyrocytes in a Rat Model of Goiter. A Possible Involvement of Fas System Endocrinology, August 1, 1998; 139(8): 3646 - 3653. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mitsiades, V. Poulaki, V. Kotoula, G. Mastorakos, S. Tseleni-Balafouta, D. A. Koutras, and M. Tsokos Fas/Fas Ligand Up-Regulation and BCL-2 Down-Regulation May Be Significant in the Pathogenesis of Hashimoto's Thyroiditis J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2199 - 2203. [Abstract] [Full Text] |
||||
![]() |
T. A. Stokes, M. Rymaszewski, P. L. Arscott, S. H. Wang, J. D. Bretz, J. Bartron, J. R. Baker Jr.;, P. Fiedler, C. E. Schaetzlein, H. Eibel;, et al. Constitutive Expression of FasL in Thyrocytes Science, March 27, 1998; 279(5359): 2015 - 2015. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |